Rheumatology News; Bruce Jancin
Nov 20th, 2018 - CHICAGO – Patients with systemic lupus erythematosus (SLE) have an incidence of treatment-resistant hypertension (TRH) twice the rate of matched controls, and all-cause mortality in affected SLE patients is sharply higher than in individuals whose SLE is not complicated by comorbid TRH, Annette Oeser reported at the annual meeting of the American College of Rheumatology. Bruce Jancin/MDedge New.
Nov 20th, 2018 - Filgotinib improved the signs and symptoms of rheumatoid arthritis among previously treated patients with highly active disease
Nov 20th, 2018 - A recent mathematical modeling analysis revealed that a modest increase in physical activity among patients with knee osteoarthritis
Nov 19th, 2018 - CHICAGO – The novel reversible B-cell inhibitor XmAb5871 showed promise for delaying loss of improvement after steroid therapy in patients with systemic lupus erythematosus in a randomized, placebo-controlled, phase 2 study. Sharon Worcester/MDedge News Dr.
Nov 19th, 2018 - A newly developed referral strategy for spondyloarthritis had a better balance of sensitivity and specificity
Nov 18th, 2018 - Psychosis, a rare manifestation of systemic lupus erythematosus (SLE), generally appears early in the disease course. But treatment can lead to good outcomes for most patients with careful follow-up, according to a large international study.
Nov 17th, 2018 - Certolizumab pegol significantly reduced disease activity and signs of inflammation compared with placebo among patients
Rheumatology News; Mitchel L. Zoler
Nov 16th, 2018 - CHICAGO – The dosage of hydroxychloroquine (HCQ) for treating patients with systemic lupus erythematosus (SLE) is often overly influenced by fear that the drug could cause blindness, Michelle A. Petri, MD, said at the annual meeting of the American College of Rheumatology.
Nov 16th, 2018 - Statin use, in combination with NSAIDs, significantly reduced disease activity among patients with ankylosing spondylitis
Nov 15th, 2018 - Patients with degenerative meniscal tear who underwent arthroscopic partial meniscectomy had substantial and similar improvements
Nov 15th, 2018 - Systemic lupus erythematosus is the number one cause among autoimmune diseases of lost potential life years in women aged 15 to 24
Nov 14th, 2018 - CHICAGO – Oral tofacitinib demonstrated strong clinical efficacy and good safety in the first-ever formal study of a Janus kinase inhibitor in patients with active, treatment-resistant dermatomyositis, Julie J. Paik, MD, reported at the annual meeting of the American College of Rheumatology.
Nov 14th, 2018 - CHICAGO – Changes in quantitative lung CT scores for scleroderma-related interstitial lung disease independently validate the superiority of hematopoietic stem cell transplantation versus cyclophosphamide for severe systemic sclerosis, according to findings in a subset of patients from the SCOT (Scleroderma: Cyclophosphamide or Transplantation) trial. Mitchel L.
Nov 14th, 2018 - Nearly one in five military officers who have had a knee injury developed radiographic osteoarthritis before 30 years of age
Nov 14th, 2018 - Women who experienced physical or emotional abuse as a child demonstrated a significantly increased risk for incident systemic lupus
Nov 13th, 2018 - At a recent meeting of the American Society for Radiation Oncology (ASTRO), Emma Holliday, MD, and her baby boy Micah were turned away from a poster session at which she was due to present novel research related to proton therapy for anal cancer. Her arrangements for off-site childcare had fallen through. When Holliday tweeted at the surprise ejection, ASTRO quickly responded, tweeting, "safety...
Nov 13th, 2018 - CHICAGO – Rituximab demonstrated a high degree of effectiveness with no safety surprises in the first-ever major clinical trial of the potent B-cell inhibitor conducted in pediatric patients with newly diagnosed or relapsing granulomatosis with polyangiitis or microscopic polyangiitis, Jennifer Cooper, MD, PharmD, said at the annual meeting of the American College of Rheumatology. Bruce Jancin/.
Nov 13th, 2018 - Advanced vascular imaging is expected to play an increasingly important role in the diagnosis and management of large-vessel vasculitis, according to a draft of the American College of Rheumatology/EULAR classification criteria for the condition.
Nov 13th, 2018 - Researchers have observed a “modest uptake” in the use of biosimilars for infliximab in the past 18 months
Nov 13th, 2018 - Nearly 50% of patients with axial spondyloarthritis are affected by chronic widespread pain, with women reporting higher pain